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Central venous stenosis: Use of transluminal angioplasty and endo-
vascular Wallstents: Central venous stenoses are a frequent complica-
tion in hemodialysis patients. These lesions lead to fistula thromboses,
arm swelling, and limit future vascular access. Stenoses are character-
ized by excellent initial response to transluminal angioplasty but rapid
recurrence. Response to angioplasty allows classification of stenoses as
elastic or nonelastic, The success of angioplasty alone in 30 patients
with central venous stenoses was compared to angioplasty and Wall-
stent placement in 11 patients with recurrent stenoses. In those who had
angioplasty alone, 7% failed angioplasty, 70% had  50% improvement
in the luminal diameter while 23% showed no improvement due to
elastic lesions. Subsequently, 81% of those with a successful result
restenosed at an average of 7.6 months while 100% of elastic lesions
occluded in an average of 2.9 months. In the 10 patients who underwent
angioplasty and Wallstent placement, 5 were due to elastic lesions with
four recurrences at a mean of 8.6 months. Four of five patients (80%)
stented with nonelastic lesions had reappearance of symptoms at a
mean of 4.2 months. We conclude that vascular stents should be
reserved for those lesions that show elastic recoil after standard
angioplasty.
Central vein stenosis is a serious complication in patients
receiving maintenance hemodialysis therapy [1—4]. We and
others have proposed a link between central vein cannulation
and the subsequent development of central venous stenoses [1].
Prior to the development of adequate treatment options, the
arm edema associated with this condition often forced removal
of the artenovenous fistula and prevented future ipsilateral
fistula placement. We have reported dramatic success with
percutaneous transluminal angioplasty (PTA) in the correction
of this condition [5] Subsequently, however, we noted a very
high recurrence rate for central vein lesions compared with
venous stenoses in other locations [6]. Davidson, using intra-
vascular ultrasound to measure intraluminal diameter before
and after angioplasty, was able to characterize the histologic
appearance of various venous stenoses and found that a signif-
icant number of central vein lesions were associated with
normal internal morphology but had dramatic elastic recoil
post-angioplasty [7]. Knowledge of these characteristics has
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allowed us to assess elastic recoil by standard angiographic
means post-angioplasty.
Recently, placement of intravascular stents has been pro-
posed as a method to prevent restenosis. Various authors have
used differing stent designs to perform this function with varing
results [8—16] The majority of these studies involve stenoses in
the vascular graft or proximal venous outflow tract with few
stentings of the central veins. We reasoned that the primary
advantage of stents would be in the treatment of recurrent
stenoses or elastic lesions that respond poorly to angioplasty.
We therefore designed the study to follow consecutive patients
focusing on central vein stenoses. In central venous stenoses
we have previously demonstrated a disproportionately high rate
of recurrence [6, 7]. In this study, we compare results obtained
using angioplasty alone with results obtained from the use of
Wallstents (Medinvent SA, Lausanne, Switzerland) in patients
with hemodialysis associated central vein stenoses which rap-
idly recurred.
Methods
Phase I
From 1987 through 1991, central venous stenosis was de-
tected in 30 chronic hemodialysis patients. The stenoses oc-
curred in the axillary, subclavian, and inominate veins as well
as the superior vena cava. Detection of central stenosis was by
a combination of elevated urea recirculation, elevated venous
dialysis pressure and arm edema. Twenty-one patients were
female, nine were male with a mean age being 56 6 years. A
total of 47 transluminal angioplasties were performed on these
30 patients.
Procedure
Upperarm venograms of the arteriovenous fistula and central
veins were performed in a standard manner as previously
described [5]. Under normal instances, the diagnostic venogram
was performed from the hemodialysis fistula. After intravenous
heparin (3000 to 5000 units) was given, percutaneous translu-
minal angioplasty was performed. With a high grade central
vein stenosis, the angioplasty approach was via the femoral
vein to minimize the size of the puncture in the high pressure
fistula circuit and to allow use of oversized balloons. Central
venous lesions were dilated with either a 8 mm, 10 mm, 12 mm,
15 mm, or double balloon (6 mm + 6 mm) diameter catheters.
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30 Patients (47 angioplasties)
Failed angoplasty >50% mprovement 50% lmjrovement
(unable to cross lesion) (nonelastic lesions) (elasic lesion)
21(70%)
Groups Males Females
Mean
age
years
Symptoms
Swelling
Poor
graft
function Unknown
Total 8 2 62.9 5 4 1
Recurrent
stenosis 4 1 53.2 2 2 1
Elastic lesions 4 1 72.6 3 2 0
The balloon diameter was determined by generally accepted
angiographic/angioplasty practices. The diameter of the balloon
utilized for dilatation of the venous lesion was determined by
the diameter of the normal reference segment of the vein. This
was obtained via direct measurement from the angiogram.
Since the angiogram includes some magnification, this results in
modest overdilatation of the venous lesion (approximately
20%). Thus, the range of 8 to 15 mm diameter balloon utiliza-
tion. Contrast cineangiography was obtained before and after
the PTA with either hand or power injection of nonionic
contrast agents. Angiographic images were analyzed with a
previously validated, commercially-available edge detection
algorithm. Percent diameter stenosis was obtained before and
alter PTA. Additionally, a total of 18 central veins were imaged
pre- and post-angioplasty by intravascular ultrasound as previ-
ously described [7]. Perforation of guidewires outside the
central venous system occurred on two occasions without any
significant clinical complication. In both instances the patients
were observed overnight prior to being dismissed.
Phase II
From 1991 through 1993, patients with elastic lesions which
showed > 50% elastic recoil with reconstitution of the vessel
diameter to  50% after angioplasty underwent endovascular
Wallstent placement. In addition, patients with a recurrence of
the same central venous stenoses within six months of a
previous angioplasty also underwent placement of an endovas-
cular stent. Thus patients with poor technical results to angio-
plasty due to elastic recoil ( 50% reconstitution of the lumen)
and patients with a documented recurrence were selected for
stent placement. A total of 10 patients underwent placement of
the endovascular stent with greater than six months of follow up
available on each patient. Due to the significant findings, the
trial was terminated and only elastic lesions were subsequently
considered for stent placement.
Procedures
Angiographic documentation of the stenotic vessel was ini-
tially performed. For stent placement, heparin (3000 to 5000
units) was administered intravenously and the stenosis or
occlusion negotiated with a catheter/guidewire combination. An
angioplasty was performed with the appropriate sized balloon.
Following angioplasty, the Walistent was manipulated into
position and deployed in the desired location within the stenosis
or occlusion. After successful deployment, the Wallstent was
dilated to 10 mm and an angiogram performed to document the
final result. Post-angiography, the catheter was removed and
pressure maintained on the puncture site for hemostasis.
All patients were followed long-term either in the Duke
University dialysis centers or by frequent communication with
the patient's personal nephrologist. Detailed follow-up was
performed to assure the absence of fistula thrombosis, arm
edema, normal urea recirculation and normal venous dialysis
pressure. If any of these criteria became abnormal, a repeat
fistulogram was performed. Follow-up was terminated if reste-
nosis was documented or upon the death of the patient.
Statistics
Data are reported as mean standard deviation. Compari-
sons between groups were done with unpaired Student's t-test.
Results
Thirty patients developed central vein stenosis during the
first phase of the study. A total of 47 percutaneous transvenous
angioplasties were performed in this group of patients. In two
patients (7%) the lesions were not able to be crossed by the
catheter and no therapy was attempted. Twenty-one patients
(70%) had > 50% improvement in the stenosis following angio-
plasty as judged by post-angioplasty venogram or by intrave-
nous ultrasound (Fig. 1). Mean follow-up for the group was 16
months. Of these, four patients (19%) had no recurrence of
symptoms during the follow up period. In contrast, 17 (81%)
patients from the group with successful angioplasty had recur-
rence at a mean of 7.6 months following the procedure and
patency rate (defined as time without recurrence of symptoms)
of 13.1 months. Seven patients (23%) had an unsatisfactory
result ( 50% improvement in the lesion) due to elastic recoil of
the vessel wall. All of these patients had loss of fistula function
by a mean of 2.9 months. This result was significant when
compared to the angioplasty patency rate in nonelastic lesions
(P < 0.05).
2(7%) 7(23%)
No recurrence Recurrence No recurrence Rcurrence
I I I
4(19)% 17(81%) 0(0%) 7(100%)
Mean time to recurrence Mean time to recurrence
7.6 months 2.9 months
Table 1. Characteristics of stented patients
Fig. 1. Outcomes of patients undergoing
angioplasty alone.
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Fig. 2. Pre-stent angiogram of an elastic central vein lesions. A. Subclavian stenosis and (B). stenosis at the junction of the subclavian vein and
superior vena cava.
In the second phase of the study, 10 patients (8 men and 2
women) underwent endovascular stent placement for their
central vein stenosis (Table 1, Figs. 2 and 3). Their mean age
was 63 years 16 years. Five were due to recurrent lesions and
five were secondary to elastic lesions that did not respond to
angioplasty. Signs and symptoms included poor blood flow with
elevated venous dialysis pressures in four, and arm edema in
association with elevented venous dialysis pressures in five and
was undocumented in one patient. The mean follow-up for the
group was 7.5 months with a median of 7.2 months (Fig. 4).
Four of five elastic lesions recurred in a mean time of 8.6
4.1 months following stenting. Total mean follow-up time for
this subgroup was 9.8 months with a median of 11.7 months.
Four of the five patients stented for recurrent nonelastic steno-
ses also had recurrence of symptoms. The mean follow-up was
5.2 months with a median of 4.4 months and the mean time to
first recurrence was 4.2 1.8 months. Two patients had
stenoses at the edge of the stent that responded to angioplasty.
Two had intimal hyperplasia in the stent, one of which re-
sponded to angioplasty while the other required a second stent
(Fig. 4). The mean patency time was significantly greater in the
stented patients with elastic lesions compared to those with
nonelastic lesions (9.8 4.5 months vs. 5.2 2.8 months; P <
0.05; Fig. 5). There was also a significant improvement of
patency rate of stented elastic lesions compared to similar
lesions undergoing angioplasty alone and in the patency rate of
nonelastic lesions undergoing angioplasty alone versus stent
placement. Because of the substantially worse outcomes in
stented, nonelastic, recurrent central vein stenoses, the trial of
stents in this patient group was terminated.
Discussion
Hemodialysis-associated central vein stenosis is emerging as
a serious vascular access complication. We initially described
this condition in 1987 and postulated that the causative factors
included previous central vein cannulation and subsequent
placement of a ipsilateral fistula with associated rapid blood
flows [1]. We theorized that the nidus of fibrosis created by the
catheter insertion expanded, driven by the turbulence created
by the increased blood flow of the downstream fistula, and
subsequently demonstrated that these lesions, in general, re-
sponded well to percutaneous transluminal angioplasty [5]. The
importance of these lesions is that, if left untreated, they result
in ipsilateral arm swelling, preventing the use of affected
extremity for vascular access.
Despite the initial success of angioplasty, long-term follow-up
from our institution showed a rapid recurrence of central
venous stenoses compared with peripheral venous stenoses [6].
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Fig. 3. Post-stent angiogram of vessel in Figure 2. Wallstent (arrow) placed to overlap both areas of stenosis with excellent blood flow post-
procedure.
10 Patients stented
I I
5 Recurrent stenosis 5 Elastic lesions
I I
First restenosis First restenosis
I I
4 4
4.2±1.8 Months 8.6±4.1 Months
Fig. 4. Outcomes of patients undergoing venous stent placement.
Davidson, evaluating the mechanisms by which transluminal
angioplasty corrects venous stenoses, noted that vessel stretch
and dissection were the mechanisms associated with successful
angioplasty. He also noted that vessel stretch followed by
>50% elastic recoil was more frequent and severe in central
venous lesions and often led to unsatisfactory angioplasty
results [7]. Neither increasing the atmospheres of pressure nor
expanding the diameter of the balloon improved the angioplasty
results in these elastic lesions. He speculated that other poten-
tial catheter-based interventions, such as stent placement,
might be beneficial.
Today, angioplasty has emerged as an essential procedure in
the treatment of central venous stenoses, especially as surgical
options in this intrathoracic area are severely limited. When
lesions are detected early, prior to, and even after total occlu-
sion, initial successful correction of the stenosis is the rule [17].
In this study, 70% of the cases had a greater than 50%
improvement in vessel diameter following angioplasty alone. Of
these patients, 19% were long-term successes with no recur-
rence. Unfortunately, 81% of these lesions recurred with a
mean time to recurrence of 7.6 months. In almost all instances,
repeat angioplasty was again successful. Stent placement in
patients with recurrent nonelastic lesions yielded a significantly
worse patency rate. Restenosis in these patients occurred in a
mean of 4.2 months versus 7.6 months in patients who under-
went repetitive angioplasty. Endothelial proliferation appears
to be the primary problem. Thus, patients with nonelastic
stenoses do not benefit from stent placement. Until new stent
materials are developed that do not lead endothelial prolifera-
tion stent placement should be avoided in patients with this type
of stenosis.
Twenty-three percent of the total lesions in this study were
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markedly elastic with less than 50% improvement following
angioplasty. One hundred percent of these stenoses recurred in
less than three months when treated with angioplasty alone.
When these patients were treated with Walistent placement,
significant improvements in patency occurred. Patency with
endovascular stents was also significantly better with elastic
lesions compared to nonelastic ones. Four patients with elastic
venous lesions showed recurrent stenosis on average in 8.6
months during a mean follow-up period of 9.8 months.
Beathard [18] recently showed poor results of Gianturco
stents in vein graft stenoses. Our results support his findings.
However, our data demonstrate that there are at least two
different histiologic types of central venous stenoses and that
these types respond differently to interventions. Nonelastic
lesions such as those caused by intimal hyperplasia or fibrosis,
which also characterize vein-fistula stenoses respond poorly to
endovascular stent placement. Elastic lesions such as those
occurring in central and proximal veins are probably histiolog-
ically different based on intravascular ultrasonographic appear-
ance and respond favorably to stent placement.
Interpretation of these findings suggests that elastic central
venous lesions are readily detectable at the time of angioplasty.
These lesions recur rapidly unless some sort of permanent
indwelling stent is placed. When an indwelling stent is placed,
the mean patency period increases dramatically over angio-
plasty alone. In contrast, nonelastic lesions do not respond to
intravascular stent placement compared to angioplasty alone.
Reprint requests to Steve J. Schwab, M.D., Division of Nephrology,
Duke University Medical Center, Box 3014, Durham, North Carolina
27710, USA.
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Fig. 5. Patency rates of angioplasty and stent
placement in elastic and nonelastic lesions.
" P < 0.05 vs. angioplasty in elastic lesions
and stents in nonelastic lesions. t,tt P < 0.05
Stents in Stents in Elastic vs. angioplasty in elastic lesions and stents in
nonelastic lesions lesions nonelastic lesion.
